INDIAN FACE
INDIAN EQUITY BENCHMARK rose nearly 1.5 percent on
Friday after domestic institutional investors turned buyers on
Thursday after a selling streak of at least 12 days, sparking a
rally in blue-chips. Traders and investors were in high spirits
ahead of the second quarter GDP and fiscal deficit for Apr-Oct
which is scheduled to be released later in the day.
Further, Today’s rally was led by the banking sector; both
private as well as the PSU banks participated in the upswing.
While Shares of Jubilant Life Sciences surged over 9% to close
at Rs138 after the company received approval from the US
health regulator to market generic version AstraZeneca's
Seroquel used for the treatment of schizophrenia.
equity tips free equity tips Stock Cash Calls stock future calls
INDIAN EQUITY BENCHMARK rose nearly 1.5 percent on
Friday after domestic institutional investors turned buyers on
Thursday after a selling streak of at least 12 days, sparking a
rally in blue-chips. Traders and investors were in high spirits
ahead of the second quarter GDP and fiscal deficit for Apr-Oct
which is scheduled to be released later in the day.
Further, Today’s rally was led by the banking sector; both
private as well as the PSU banks participated in the upswing.
While Shares of Jubilant Life Sciences surged over 9% to close
at Rs138 after the company received approval from the US
health regulator to market generic version AstraZeneca's
Seroquel used for the treatment of schizophrenia.
equity tips free equity tips Stock Cash Calls stock future calls
0 Comments